Ads
related to: sanofi pharmaceuticals products- Before & After Photos
See the Before and After of What
A Treatment Option Can Do For You.
- Side Effects
What You Need To Know
About Benefits and Side Effects
- Psoriasis Symptoms
Learn More Information About
The Symptoms of Plaque Psoriasis.
- Sign Up for Info
Get Updates, Answers, and Resources
For Treatment Support
- Watch Videos
Watch A Video To Learn More
About A Treatment Option.
- Save With Insurance
Get Help & Information to Make
Your Co-Pay More Affordable.
- Before & After Photos
myalloy.com has been visited by 10K+ users in the past month
Search results
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 7 hours agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via Yahoo News· 15 hours agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.
Market Watch· 15 hours agoFrench pharmaceutical company Sanofi said that the priority review date in the U.S. for its chronic obstructive pulmonary disease treatment, Dupixent has ...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 7 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 15 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target ...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga· 5 hours agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
2 Biotech Stocks to Buy in May
Motley Fool via Yahoo Finance· 6 days agoRegeneron Pharmaceuticals Regeneron Pharmaceuticals is another highly innovative biotech with several growth drivers in its arsenal. ...drivers is cancer...
PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 6 days agoPNC Financial Services Group Inc. lowered its position in Sanofi (NASDAQ:SNY – Free Report) by 48.1% during the fourth quarter, Holdings Channel reports. The institutional ...
Social Media Physician Endorsements Raise Prickly Ethical Questions
MedPage Today· 2 days agoIn 2022, 28 U.S. physicians endorsing drugs or devices on X (previously Twitter) made nearly $1.5...
